Taiwan FDA registration fa74f5d128a355b75312d12d77d36da7

Bondis Complement Hemolysis Analysis Kit (Unsterilized)

TW: 邦迪斯補體溶血分析套組（未滅菌）

Taiwan·Risk Class 1·THE BINDING SITE GROUP LIMITED·Registered Oct 29, 2010 – Oct 29, 2025Expired

Registration details

Analysis ID: fa74f5d128a355b75312d12d77d36da7
Customs Code: DHA04400943202

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: Limited to the first level identification scope of the "Complement Reagent (C.4100) Classification and Grading Management Measures for Medical Devices".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.4100 Complement reagents
Import Information: import

Dates and status

Registration Date: Oct 29, 2010
Expiry Date: Oct 29, 2025

About this record

Access comprehensive regulatory information for Bondis Complement Hemolysis Analysis Kit (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number fa74f5d128a355b75312d12d77d36da7 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.